Launch week offerEnds in00h00m00s

annual Promonthly Pro

Luca Mazzarella

European Institute of Oncology

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy Professors in Biostatistics Biostatistics professors in Italy

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Enrico Berrino

Università degli Studi di Foggia Dipartimento di Scienze Mediche e Chirurgiche

ITALY

View details

Monica Rodolfo

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Elena Trombetta

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

ITALY

View details

Alessandro Rambaldi

University of Milan

ITALY

View details

Gabriele Bucci

Computational Biologist

Ospedale San Raffaele

ITALY

View details

Francesco Strati

Group Leader

University of Milano-Bicocca

ITALY

View details

Mohamed Elgendy

Group Leader

Technische Universität Dresden

GERMANY

View details

Francesco Nicassio

Senior Researcher Tenured (Principal Investigator)

Istituto Italiano di Tecnologia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luca Mazzarella

Research Interests

Make your next move.

Explore related searches

Articles (18)

Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres

Accuracy of renovo predictions on variants reclassified over time

Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion

Clinical bioinformatics desiderata for molecular tumor boards

Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres (vol 22, 1, 2024)

Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance

PROgnostic Signature in stage II colon cancer (CC) patients enrolled in the phase III clinical trial TOSCA: PROSIT study

PoreMeth2: decoding the evolution of methylome alterations with Nanopore sequencing

iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis

Author Correction: High-resolution Nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias

High-resolution Nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias

Benchmarking and improving the performance of variant-calling pipelines with RecallME

GASOLINE: detecting germline and somatic structural variants from long-reads data

Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses

Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial

Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell carcinoma of the penis: Subgroup analysis of the PEVOsq basket trial

Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic vulvar and vaginal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial

The genomic landscape of radiotherapy-induced breast angiosarcoma: An alleanza contro il cancro (ACC) initiative for an unmet need in rare tumors

Collaborators (8)

Enrico Berrino

Monica Rodolfo

Elena Trombetta

Alessandro Rambaldi

Gabriele Bucci

Francesco Strati

Mohamed Elgendy

Francesco Nicassio

Make your next move.